| [1] |
. Cell，2012，149（1）：22-35.
|
| [2] |
Annibali D，Whitfield JR，Favuzzi E，et al. Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis［J］. Nat Commun，2014，5：4632.
|
| [3] |
Li ST，Huang，Shen S，et al. Myc-mediated SDHA acetylation triggers epigenetic regulation of gene expression and tumorigenesis［J］. Nat Metab，2020，2（3）：256-269.
|
| [4] |
Faubert B，Solmonson A，DeBerardinis RJ. Metabolic reprogramming and cancer progression［J］. Science，2020，368（6487）：5473.
|
| [5] |
Kim JW，Zeller KI，Wang YY，et al. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays［J］. Mol Cell Biol，2004，24（13）：5923-5936.
|
| [6] |
Liberti MV，Locasale JW. The Warburg effect：how does it benefit cancer cells［J］？Trends Biochem Sci，2016，41（3）：211-218.
|
| [7] |
Edmunds LR，Sharma L，Kang A，et al. C-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate［J］. J Biol Chem，2015，290（33）：20100.
|
| [8] |
Cunningham JT，Moreno MV，Lodi A，et al. Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme，PRPS2，to drive cancer［J］. Cell，2014，157（5）：1088-1103.
|
| [9] |
Davidson SM，Papagiannakopoulos T，Olenchock BA，et al. Environment impacts the metabolic dependencies of ras-driven non-small cell lung cancer［J］. Cell Metab，2016，23（3）：517-528.
|
| [10] |
Mayers JR，Vander Heiden MG. Nature and nurture：what determines tumor metabolic phenotypes［J］？Cancer Res，2017，77（12）：3131-3134.
|
| [11] |
Carroll PA，Diolaiti D，McFerrin L，et al. Deregulated Myc requires MondoA/MLx for metabolic reprogramming and tumorigenesis［J］. Cancer Cell，2015，27（2）：271-285.
|
| [12] |
Nair SK，Burley SK. X-ray structures of myc-max and mad-max recognizing DNA - molecular bases of regulation by proto-oncogenic transcription factors［J］. Cell，2003，112（2）：193-205.
|
| [13] |
Dang CV. Gene regulation：fine-tuned amplification in cells［J］. Nature，2014，511（7510）：417-418.
|
| [14] |
Sabò A，Kress TR，Pelizzola M，et al. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis［J］. Nature，2014，511（7510）：488-492.
|
| [15] |
Walz S，Lorenzin F，Morton J，et al. Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles［J］. Nature，2014，511（7510）：483-487.
|
| [16] |
Macek P，Cliff MJ，Embrey KJ，et al. Myc phosphorylation in its basic helix-loop-helix region destabilizes transient α-helical structures，disrupting Max and DNA binding［J］. J Biol Chem，2018，293（24）：9301-9310.
|
| [17] |
Zhou W，Liotta LA，Petricoin EF. The Warburg effect and mass spectrometry-based proteomic analysis［J］. Cancer Genom Proteom，2017，14（4）：211-218.
|
| [18] |
Gao Q，Zhu HW，Dong LQ，et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma［J］. Cell，2019，179（2）：561-577.
|
| [19] |
Ananieva E. Targeting amino acid metabolism in cancer growth and anti-tumor immune response［J］. World J Biol Chem，2015，6（4）：281-289.
|
| [20] |
Gentric G，Mieulet V，Mechta-Grigoriou F. Heterogeneity in cancer metabolism：new concepts in an old field［J］. Antioxid Redox Signal，2017，26（9）：462-485.
|
| [21] |
Coller HA. MYC sets a tumour-stroma metabolic loop［J］. Nat Cell Biol，2018，20（5）：506-507.
|
| [22] |
Yan W，Wu X，Zhou W，et al. Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells［J］. Nat Cell Biol，2018，20（5）：597-609.
|
| [23] |
San-Millán I，Brooks GA. Reexamining cancer metabolism：lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect［J］. Carcinogenesis，2017，38（2）：119-133.
|
| [24] |
Wise DR，DeBerardinis RJ，Mancuso A，et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction［J］. Proc Natl Acad Sci U S A，2008，105（48）：18782-18787.
|
| [25] |
Shen LL，O''Shea JM，Kaadige MR，et al. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP［J］. Proc Natl Acad Sci U S A，2015，112（17）：5425-5430.
|
| [26] |
Israelsen WJ，Vander Heiden MG. Pyruvate kinase：Function，regulation and role in cancer［J］. Semin Cell Dev Biol，2015，43：43-51.
|
| [27] |
Patra KC，Hay N. The pentose phosphate pathway and cancer［J］. Trends Biochem Sci，2014，39（8）：347-354.
|
| [28] |
Morrish F，Noonan J，Perez-Olsen C，et al. Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry［J］. J Biol Chem，2010，285（47）：36267-36274.
|
| [29] |
Wang RN，Dillon CP，Shi LZ，et al. The transcription factor myc controls metabolic reprogramming upon T lymphocyte activation［J］. Immunity，2011，35（6）：871-882.
|
| [30] |
Yang M，Vousden KH. Serine and one-carbon metabolism in cancer［J］. Nat Rev Cancer，2016，16（10）：650-662.
|
| [31] |
Anderton B，Camarda R，Balakrishnan S，et al. MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancer［J］. EMBO Rep，2017，18（4）：569-585.
|
| [32] |
Sun LC，Song LB，Wan QF，et al. cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions［J］. Cell Res，2015，25（4）：429-444.
|
| [33] |
Still ER，Yuneva MO. Hopefully devoted to Q：targeting glutamine addiction in cancer［J］. Br J Cancer，2017，116（11）：1375-1381.
|
| [34] |
Bhutia YD，Ganapathy V. Glutamine transporters in mammalian cells and their functions in physiology and cancer［J］. Biochim Biophys Acta，2016，1863（10）：2531-2539.
|
| [35] |
Qing GL，Li B，Vu A，et al. ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation［J］. Cancer Cell，2012，22（5）：631-644.
|
| [36] |
Gao P，Tchernyshyov I，Chang TC，et al. C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism［J］. Nature，2009，458（7239）：762-765.
|
| [37] |
Csibi A，Lee G，Yoon SO，et al. The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation［J］. Curr Biol，2014，24（19）：2274-2280.
|
| [38] |
Shroff EH，Eberlin LS，Dang VM，et al. MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism［J］. Proc Natl Acad Sci U S A，2015，112（21）：6539-6544.
|
| [39] |
Korangath P，Teo WW，Sadik H，et al. Targeting glutamine metabolism in breast cancer with aminooxyacetate［J］. Clin Cancer Res，2015，21（14）：3263-3273.
|
| [40] |
Liu W，Hancock CN，Fischer JW，et al. Proline biosynthesis augments tumor cell growth and aerobic glycolysis：involvement of pyridine nucleotides［J］. Sci Rep，2015，5：17206.
|
| [41] |
Yuneva MO，Fan TW，Allen TD，et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type［J］. Cell Metab，2012，15（2）：157-170.
|
| [42] |
Bott AJ，Peng IC，Fan YJ，et al. Oncogenic myc induces expression of glutamine synthetase through promoter demethylation［J］. Cell Metab，2015，22（6）：1068-1077.
|
| [43] |
Dejure FR，Eilers M. MYC and tumor metabolism：chicken and egg［J］. EMBO J，2017，36（23）：3409-3420.
|
| [44] |
Ma XX，Chong L，Tian R，et al. Identification and quantitation of lipid C=C location isomers：a shotgun lipidomics approach enabled by photochemical reaction［J］. Proc Natl Acad Sci U S A，2016，113（10）：2573-2578.
|
| [45] |
DeBerardinis RJ，Chandel NS. Fundamentals of cancer metabolism［J］. Sci Adv，2016，2（5）：e1600200.
|
| [46] |
Keckesova Z，Donaher JL，de Cock J，et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state［J］. Nature，2017，543（7647）：681-686.
|
| [47] |
Pascual G，Avgustinova A，Mejetta S，et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36［J］. Nature，2017，541（7635）：41-45.
|
| [48] |
Tadros S，Shukla SK，King RJ，et al. De novo lipid synthesis facilitates gemcitabine resistance through endoplasmic Reticulum stress in pancreatic cancer［J］. Cancer Res，2017，77（20）：5503-5517.
|
| [49] |
Jeon SM，Chandel NS，Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress［J］. Nature，2012，485（7400）：661-665.
|
| [50] |
Gouw AM，Margulis K，Liu NS，et al. The MYC oncogene cooperates with sterol-regulated element-binding protein to regulate lipogenesis essential for neoplastic growth［J］. Cell Metab，2019，30（3）：556-572.
|
| [51] |
Casciano JC，Perry C，Cohen-Nowak AJ，et al. MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer［J］. Br J Cancer，2020，122（6）：868-884.
|
| [52] |
Zhong CX，Fan LM，Yao F，et al. HMGCR is necessary for the tumorigenecity of esophageal squamous cell carcinoma and is regulated by Myc［J］. Tumour Biol，2014，35（5）：4123-4129.
|
| [53] |
Leone RD，Powell JD. Metabolism of immune cells in cancer［J］. Nat Rev Cancer，2020，20（9）：516-531.
|
| [54] |
Ferrer CM，Sodi VL，Reginato MJ. O-GlcNAcylation in cancer biology：linking metabolism and signaling［J］. J Mol Biol，2016，428（16）：3282-3294.
|
| [55] |
Sodi VL，Khaku S，Krutilina R，et al. mTOR/MYC axis regulates O-GlcNAc transferase expression and O-GlcNAcylation in breast cancer［J］. Mol Cancer Res，2015，13（5）：923-933.
|
| [56] |
Zeng Q，Zhao RX，Chen J，et al. O-linked GlcNAcylation elevated by HPV E6 mediates viral oncogenesis［J］. Proc Natl Acad Sci U S A，2016，113（33）：9333-9338.
|
| [57] |
Li T，Song L，Zhang Y，et al. Molecular mechanism of c-Myc and PRPS1/2 against thiopurine resistance in Burkitt''s lymphoma［J］. J Cell Mol Med，2020，24（12）：6704-6715.
|
| [58] |
Restelli V，Lupi M，Chilà R，et al. DNA damage response inhibitor combinations exert synergistic antitumor activity in aggressive B-cell lymphomas［J］. Mol Cancer Ther，2019，18（7）：1255-1264.
|
下载:
